Abstract
Yanagisawa and colleagues (1) isolated a long sought endogenous vasoconstricting peptide family, in part from endothelial cells: This peptide family was named the endothelins (ET). Endothelin-1 (ET-1), ET-2, and ET-3 comprise those peptides produced in a variety of tissues, where they act as modulators of important cell processes. These peptides act through binding to two well-defined classes of transmembrane receptors, ETAand ETBwhere the stimulation of several signaling pathways leads to their mitogenic, vasoconstricting, and developmental actions. In this chapter, the details of ET synthesis and regulation and action and defined physiologic and pathophysiologic roles are examined In particular, there is an emphasis on defining the roles of ET-1 as an important vascular hormone.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kokayash M, Mitsui Y, Yazaki, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332: 411–415.
Simonson MS Endothelins: multifunctional renal peptides. Physiol Rev 1993;73:375–411.
Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:328–415.
Nakamura S, Naruse M, Naruse K, Demura H, Uemura H Immunocytochemical localization of endothelin in cultured bovine endothelial cells. Histochemistry 1990;94:475–477.
Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T. The human preproendothelin-1 gene. J Biol Chem 1989;264:14,954–14,959.
DeNucci G, Thomas R, D’Orleans JP, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797–9800.
Vijayayaraghavan J, Scicli AG, Carretero OA, Slaughter C, Moomaw C, Hersh LB. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem 1990:265:14,150–14,155.
Yoshimoto S, Ishizaki Y, Sasaki T, Murota S-I. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke 1991;22:378–383.
Lerman A, Edwards BS, Hallet JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. New Engl J Med 1991;325:997–1001.
Wei C-M, Lermin A, Rodeheffer RJ, McGregor CGA, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC Jr. Endothelin in human congestive heart failure. Circulation 1994;89: 1580–1586.
Shinmi O, Kimura S, Sawamura T, Sugita Y, Yoshizawa T, Uchiyama Y, Yanagisawa M, Goto K, Masaki T, Kanazawa I. Endothelin-3 is a novel neuropeptide: isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brain. Biochem Biophys Res Commun 1989;164:587–593.
Lee M-E, Bloch KD, Clifford JA, Quertermous T. Functional analysis of the endothelin gene promoter. J Biol Chem 1990;265:10,446–10,450.
Wilson DB, Dorfman DM, Orkin SH. A nonerythroid GATA-binding protein is required for function of the human preproendothelin-1 promoter in endothelial cells. Mol Cell Biol 1990;10:4854862.
Hu R-M, Chuang E, Prins B, Kashyup M, Frank HJL, Levin ER. High density lipoproteins stimulate the production and secretion of endothelin-1 from cultured bovine aortic endothelial cells. J Clin Invest 1994;93:1056–1062.
Hu R-M, Levin ER, Pedram A, Frank HJL. Atrial natriuretic peptide inhibits the translation and secretion of endothelin from cultured bovine aortic endothelial cells: mediation through C receptors. J Biol Chem 1992;267:17,384–17,389.
Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, Damiane D, Yanagasawa M. ECE-1: a membrane-bound metallopeptidase that catalyzes the proteolytic activation of big endothelin-1. Cell 1994;78:473–485.
Arai H, Hori S, Aramon I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730–732.
Simonsen MS, Dunn MJ. Cellular signalling by peptides of the endothelin gene family. FASEB J 1990;4:2989–3000.
Goligorsky MS, Tsukahara H, Magazine H, Andersen TT, Malik AB, Bahou WF. Termination of endothelin signaling: role of NO. J Cell Physiol 1994;158:485–494.
Chun M, Lin HL, Henis YI, Lodish HF. Endothelin-induced endocytosis of cell surface ETA receptors. J Biol Chem 1995;270:10,855–10,860.
Herman WH, Simonsen MS. Nuclear signalling by endothelin-1. J Biol Chem 1995;270(19):11,654–11,661.
Simonson MS, Herman WH. Protein kinase C and protein tyrosine kinase activity contribute to mito-genic signalling by endothelin-1. J Biol Chem 1993;268:9347–9357.
Koide M, Kawahara Y, Tsuda T, Ishida Y, Shii K, Yokoyama M. Endothelin stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J Hypertens 1992;10:1173–1182.
Simonsen MS, Wann S, Mene P, Dubyak GR, Kester M, Nakazato Y, Sedor JR, Dunn MJ. Endothelin stimulates phospholipase C, Na+/H+exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 1989;83:708–712.
Shubeita HE, Harris HN, McDonough PM, Knowlton KU, Glembotski C, Brown JH, Chien KR. Endothelin induction of sarcomere assembly and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 1990;265:20,555–20,562.
Neyses L, Nouskas J, Vetter H. Inhibition of endothelin-1 induced myocardial protein synthesis by an antisense oligonucleotide against the early response gene-1. Biochem Biophys Res Commun 1991;181:22–27.
Pai J-K, Dobeck EA, Bishop WR. Endothelin-1 activates phospholipase D and thymidine incorporation in fibroblasts overexpressing protein kinase Cßm. Cell Reg 1991;2:897–903.
Aramon I, Nakanishi S. Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J Biol Chem 1992;267:12,468–12,474.
Noveral JP, Rosenberg SM, Anbar RA, Pawlowski NA, Grunstein MM. Role of endothelin-1 in regulating proliferation of cultured rabbit airway smooth muscle cells. Am J Physiol 1992;263:L317–L324.
Ono K, Tsujimoto G, Sakamoto A, Eto K, Masaki T, Ozaki Y, Satake M. Endothelin-A receptor mediates cardiac inhibition by regulating Caz+ and potassium currents. Nature 1994;370:301–304.
Sakurai T, Yanagagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732–735.
Wang Y, Rose PM, Webb ML, Dunn W. Endothelin stimulate mitogen-activated protein kinase cascade through either ETAor ETB. Am J Physiol 1994;267:C1130–C1135.
Koh E, Morimoto S, Kim S, Nabata T, Miyashita Y, Ogihara T. Endothelin stimulates Na/H exchange in vascular smooth muscle cells. Biochem Int 1990;20:375–380.
Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F. Endothelin receptor subtype B mediates synthesis of NO by cultured bovine endothelial cells. J Clin Invest 1993;91:1367–1373.
Filep JG, Herman F, Battistini B, Chabrier PE, Braquet P, Sirois P. Antiaggregatory and hypotensive effects of endothelin 1 in beagle dogs: role for prostacyclin. J Cardiovasc Pharmacol1991;17:S216–S218.
Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, Yanagisawa M. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 1994;79:1277–1285.
Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A, Yanagisawa M. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 1994;79:1267–1276.
Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWitt D, Yanagisawa M, Chakravarti A. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung’s Disease. Cell 1994;79:1257–1266.
Karne S, Jayawickreme J, Lerner MB. Cloning and characterization of an endothelin-3 specific receptor (ETc receptor) from Xenopus Laevis dermal melanophores. J Biol Chem 1993;268:19,126–19,133.
Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover RL. Role of endothelin in cyclosporineinduced glomerular dysfunction. Kidney Int 1990;37:1487–1491.
Ferrario RG, Foulkes R, Salvatti P, Patron C. Hemodynamic and tubular effects of endothelin and thromboxane in the isolate perfused rat kidney. Eur J Pharmacol. 1989;171:127–134.
Goetz KL, Wang BC, Madwed JB, Zhu JL, LeadlyRI.Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 1988;255:R1064–R1068.
Sadoshima J-I, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993;75:977–984.
Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Marumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 1993;92:398–403.
Cozza EN, Chiou S, Gomez Sanchez CE. Endothelin-1 potentiation of angiotensin II. Stimulation of aldosterone production. Am J Physiol 1992;262:R85–R89.
Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Fiaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM. Effect of captopril on Mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669–677.
Boulanger C, Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived NO. J Clin Invest 1990;85:587–590.
Prins B, Hu R-M, Nazario B, Pedram A, Frank HJL, Weber MA, Levin ER. Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 1994;269:11,938–11,944.
Kohno M, Yasunari K, Yokokawa K, Murakawa K, Horio T, Takeda T. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J Clin Invest 1991;87:1999–2004.
Thiemermann C, Lidbury PS, Thomas GR, Vane JR. Endothelin-1 releases prostacyclin and inhibitsex vivoplatelet aggregation in the anesthetized rabbit. J Cardiovasc Pharm 1989;13:5138–5141.
Miura K, Yukimura T, Yamashita, Y, Shimmen T, Okumura M, Yamanaka S, Imanishi M, Yamamoto K. Renal and femoral vascular responses to endothelin-1 in dogs: role of prostaglandins J Pharmacol Exp Ther 1991;256:11–17.
Macquin-Mavier I, Levame M, Istin N, Harf A. Mechanism of endothelin-mediated bronchoconstriction in the guinea pig. J Pharmacol Exp Ther 1989;250:740–745.
Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994;344:852–854.
Seo B, Oemar BS, Siebenmann R, von Segesser L, Luscher T. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994;89:1203–1208.
Tabuchi Y, Nakamuru M, Rakugi H, Nagano M, Mikami H, Ogihara T. Endothelin inhibits presynaptic adrenergic neurotransmission in rat mesenteric artery. Biochem Biophys Res Commun 1989;161:803–808.
Lopez JA, Armstrong ML, Piegors DJ, Heistad DD. Vascular responses to endothelin-1 in atherosclerotic primates. Arteriosclerosis 1990;10:1113–1118.
Scheibinger RJ, Gomez-Sanchez CE. Endothelin: a potent stimulus of atrial natriuretic peptide secretion by superfused rat atria and its dependency on Caz+. Endocrinology 1990;127:119–125.
Battistini B, D’Orleans-Juste P, Sirois P. Endothelins: circulating plasma levels and presence in other fluids. Lab Invest 1993;68:600–628.
Kurihara H, Yamaoki K, Nahai R, Yoshizumi M, Takaku F, Satoh H, Inui J, Yazaki Y. Endothelin: a potent vasoconstrictor associated with coronary vasospasm. Life Sci 1989;44:1937–1943.
Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Endothelin in myocardial infarction. Nature 1990;344:114.
Grover GJ, Dzwonczk S, Parham CS. The endothelin-1 receptor antagonist BQ-123 reduced infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 1993;27:1613–1618.
Brunner F, Du Toit EF, Opie LH. Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol 1992;24:1291–1305.
Daggassan PH, Breu V, Clozel M, and Clozel J-P. Role of endothelin during reperfusion after ischemia in isolated perfused rat heart. J Cardiovasc Pharmacol 1994;24:867–874.
Pacher R, Bergler-Klein J, Globits S, Teufelsbauer H, Schuller M, Krauter A, Ogris E, Rodler S, Wutte M, Hartter E. Plasma Big-endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. Am J Cardiol 1993;71:1293–1299.
Omland T, Li RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994;89: 1573–1579.
Lerman A, Hildebrand FL, Aarhus LL, Burnett JC. Endothelin has biological actions at physiologic concentrations. Circulation 1991;83:1808–1814.
Rosolowsky LJ, Campbell WB. Endothelin enhances adrenocorticotropin-stimulated aldosterone release from cultured bovine adrenal cells. Endocrinology 1990; 126:1860–1866.
Clavell AL, Wright RS, Thomas MR, Brandt RR, Opgenorth TJ, Burnett JC. Elevated endogenous endothelin mediates systemic vasoconstriction in experimental chronic congestive heart failure. J Am Coll Cardiol 1994;172A.
Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, Elliott JD, Ohlstein EH. A role for endogenous endothelin -1 in neointimal formation after rat carotid artery balloon angioplasty. Circ Res 1994;75:190–197.
Oliver FJ, de laRubia G, Feener EP, Lee M-E, Loeken MR, Shiba T, Quertermous T, King GL. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem 1991;266: 23,251–23,256.
Frank HJL, Levin ER, Hu R-M, Pedram A. Insulin stimulates endothelin binding and action on cultured vascular smooth muscle. Endocrinology 1993;133:1092–1097.
Yokokawa K, Tahara H, Kohno M, Murakawa K-I, Yasunari K, Nakagawa K, Hamada T, Otani S, Yanagisawa M, Takeda T. Hypertension associated with endothelin-secreting malignant hemangioendothelioma. Ann Int Med 1991;114:213–215.
Kurihara Y, Kurihara H, Suzuki H, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994;368:703–710.
Deng AY, Dene H, Pravenec M, Rapp JP. Genetic mapping of two new blood pressure quantitative trail loci in the rat by genotyping endothelin system genes. J Clin Invest 1994;93:2701–2709.
Branch DW, Dudley DJ, Mitchell MD. Preliminary evidence for homeostatic mechanism regulating endothelin production in pre-eclampsia. Lancet 1991; 337:943–945.
Schumacher WA, Steinbacher TE, Allen GT, Ogletree M. Role of thromboxane receptor activation in the bronchospastic response to endothelin. Prostaglandins 1990;40:71–79.
Mattoli S, Mezzetti M, Riva G, Allegra L, Fasoli A. Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin like material from bronchial epithelial cells. Am J Resp Cell Mol Biol 1990;3:145–151.
Mattoli S, Soloperto M, Marinin M, Fasoli A. Levels of endothelin in the bronchoalveolar lavage fluid of patients with symptomatic asthma and reversible airflow obstruction. J Allergy Clin Immunol 1991;88:376–384.
Giaid A, Michel RP, Stewart DJ, Sheppard M, Corrin B, Hamid Q. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 1993;341:1550–1554.
Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with primary pulmonary hypertension. New Engl J Med 1993;328:1732–1739.
Bouchman TE, Brookshire CA. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 1991;88:310–314.
Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993;93:2144–2149.
Fogo A, Hellings SE, Inagami T, Kon V. Endothelin receptor antagonism is protective in in vivo acute cyclosprorine toxicity. Kidney Int 1992;42:770–774.
Chan L, Chittinnandana J, Shapiro JI, Shanley PF, Schrier RW. Effect of an endothelin receptor antagonist on ischemic acute renal failure. Am J Physiol 1994;266:F135–F138.
Clozel M, Breu V,.Burri K, et al. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 1993;365:759–761.
Coceani F, Kelsey ZL. Endothelin-1 release from lamb ductus arteriosis: relevance to postnatal closure of the vessel. Can J Physiol Pharmacol 1991;69:218–221.
Kurihara K, Kurihara H, Oda K, Nagai R, Ishikawa T, Yazaki Y. Aortic arch malformations and ventriculae septal defect in mice deficient in endothelin-1. J Clin Invest 1995;96:293–300.
Levin ER. Atrial natriuretic peptide and endothelin: interactions in the central nervous system and periphery. Mol Cell Neurosci 1991;2:189–201.
Levin ER, Frank HJL, Pedram A. Endothelin receptor expression in fetal rat diencephalon. J Neurochem 1992;58:659–666.
Vigne P, Farre AL, Frelin C. Na+-K+-CI-cotransporter of brain capillary endothelial cells. J Biol Chem 1994;31:19,925–1 9,930.
Yamamoto T, Kimura T, Ota K, et al. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion. Am J Physiol 1992;262:E856–E862.
Ouchi Y, Nakamura S, Souza AC, et al. Central effects of endothelin on blood pressure in conscious rats. Am J Physiol 1989;256:H1747—H1751.
Samson WK, Murphy TC. Antidisogenic actions of endothelin are exerted via the endothelin-A receptor in the brain. Am J Physiol 1993;265:R1212- R1215.
Shichiri M, Hirata Y, Kanno K, Ohta K, Emori T, Marumo F. Effect of endothelin-1 on release ofargininevasopressin from perifused rat hypothalamus. Biochem Biophys Res Commun 1989;163:1332–1337.
Kanyicksa B, Burris TP, Freeman ME. Endothelin-3 inhibits prolactin and stimulates LH, FSH, and TSH secretion from pituitary cell culture. Biochem Biophys Res Commun 1991;174:338–343.
Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin1 in acute ischemic stroke. Stroke 1992;23:1014–1016.
Encabo A, Ferrer M, Marin J, Villamor J, Bafagon G. Vasoconstrictive responses elicited by endothelin in bovine cerebral arteries. Gen Pharmacol 1992;23:263–267.
Suzuki R, Masaoka H, Hirata Y, Marumo F, Isotani E, Hirakawa K. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarrachnoid hemorrhage. J Neurosurg 1992;77:96–100.
Huneidi AHS, Thiemermann C, Lidbury PS, et al. ET-1 and big ET cause subarrachnoid hemorrhage in the anesthetized rabbit. J Cardiovasc Pharmacol 1991;17:5492—S495.
Willette RN, Zhang H, Mitchell MP, et al. Nonpeptide endothelin antagonist: cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke 1994;25:2450–2456.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Levin, E.R. (1996). The Endothelin Peptides. In: Sowers, J.R. (eds) Endocrinology of the Vasculature. Contemporary Endocrinology, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0231-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0231-8_4
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6672-3
Online ISBN: 978-1-4612-0231-8
eBook Packages: Springer Book Archive